Category

Ensayos clínicos

MIND Matters | Quarterly Newsletter | Winter 2021

Por Ensayos clínicos, Comentario, Eventos comunitarios, COVID-19, En las noticias, Longitudinal Cohort, Participants, MENTE UCI

Message from the Director Happy New Year, Friends of UCI MIND! For many of us, a New Year brings the promise of fresh starts and new beginnings. In 2021, it also means a welcomed good-bye to a very long 2020. Despite the challenges that 2020 brought, it also brought progress that must now continue in 2021. This includes progress in social justice, progress in fighting the COVID-19 pandemic, and progress in research to rid the world of Alzheimer’s disease and related dementias. UCI MIND is committed to contributing to further progress in each of these areas. Though the COVID-19 pandemic…

El cargo MIND Matters | Quarterly Newsletter | Winter 2021 apareció primero en MENTE UCI.

Lee mas

Holidays during COVID-19

Por Ensayos clínicos, Comentario, COVID-19, Longitudinal Cohort, Participants, MENTE UCI

Have you noticed the Holiday decorations popping up at shopping malls already? Yes, the Holiday Season is upon us. This year, due to the COVID-19 pandemic, we all need to carefully plan our social gatherings, meals, and guests in our homes. Hopefully, you will find some helpful hints here so you can safely navigate all the Holidays you will celebrate this year.   The very best gift you can give yourself, your loved ones and your friends is to make sure you get your flu vaccine as soon as possible. Keep in mind that grocery stores and malls will be getting…

El cargo Holidays during COVID-19 apareció primero en MENTE UCI.

Lee mas

MIND Matters | Quarterly Newsletter | Fall 2020

Por Ensayos clínicos, Comentario, Eventos comunitarios, COVID-19, En las noticias, Longitudinal Cohort, Participants, MENTE UCI

Message from the Director   Dear Friends of UCI MIND, As the COVID-19 pandemic continues to impact our lives this fall, the fight to solve Alzheimer’s disease and related dementias (ADRD) must charge forward. This November, the U.S. FDA will convene an advisory committee to assess potential approval of Biogen’s aducanumab, a monoclonal antibody in development for treatment of early AD. We will watch closely as aducanumab could be the first new approved drug for AD since 2005. Regardless of the outcome of the meeting and subsequent FDA decision – anticipated in March 2021 – this represents a milestone for…

El cargo MIND Matters | Quarterly Newsletter | Fall 2020 apareció primero en MENTE UCI.

Lee mas

Welcome to the UCI Stem Cell Research Center’s Blog!

Por alzheimer's, CIRM, Ensayos clínicos, Dr. Randal Mills, Events, Huntington's disease, OCCCA, Research, Retinitis pigmentosa, Scientists, spinal cord injury, Stem Cell Awareness Day, Stem Cell Research Center, Stem Cells, stroke, UCI

Since this is an inaugural blog, I would like to first introduce myself, Randal Berg, MBA, PhD as the current Chief Administrative Officer (CAO) at the UCI Stem Cell Research Center (SCRC). I am excited to have joined a team … Continue reading

Lee mas
Español de México